α1-acid glycoprotein: An acute phase protein with inflammatory and immunomodulating properties

Cytokine and Growth Factor Reviews

Volumn 14, Issue 1, 2003, Pages 25-34

  Hochepied, Tino ^a   Berger, Franklin G ^b   Baumann, Heinz ^c   Libert, Claude ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

1 Acid glycoprotein; Acute phase; Immunity; Inflammation

Indexed keywords

ACUTE PHASE PROTEIN; CHEMOKINE RECEPTOR CCR5; CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GALACTOSAMINE; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; OROSOMUCOID; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; PLASMINOGEN ACTIVATOR INHIBITOR 1; POKEWEED MITOGEN; SIALIC ACID; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR; ZYMOSAN;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; COLITIS; CYTOKINE RELEASE; HEMORRHAGIC SHOCK; HEPATITIS; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE; MOLECULAR WEIGHT; NEPHROTIC SYNDROME; NEUTROPHIL; NONHUMAN; PANCREATITIS; PERITONITIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REPERFUSION INJURY; SEPSIS; SHORT SURVEY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; WOUND HEALING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD PLATELETS; CYTOKINES; HUMANS; INFLAMMATION; NEUTROPHILS; OROSOMUCOID; WOUND HEALING;

MAMMALIA;

EID: 0037301226     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(02)00054-0     Document Type: Short Survey

References (96)

1. 1-acid glycoprotein. Biochim Biophys Acta 1977;492:291-302.
2. 1-acid glycoproteins. J Biol Chem 1981;256:8476-84.
3. 1-Acid glycoprotein. Biochim Biophys Acta 2000;1482:157-71.
4. 1-acid glycoprotein as indicators of rheumatoid arthritis activity. Clin Chim Acta 1987;163:185-90.
5. Turner GA. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 1992;208:149-71.
6. 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 1993;177:657-66.
7. van Dijk W, Turner GA. Mackiewicz A. Changes in glycosylation of acute-phase proteins in health and disease: occurrence, regulation and function. Glycol Dis 1994;1:5-14.
8. 1-Acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconjugate J 1995;12:227-33.
9. Mackiewicz A, Ganapathi MK, Schultz D, Kushner I. Monokines regulate glycosylation of acute-phase proteins. J Exp Med 1987;166:253-8.
10. 2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines. Scand J Immunol 1989;29:265-71.
11. 1-acid glycoprotein Studies with human sera primary cultures of human hepatocytes and transgenic mice. Biochem J 1991;276:343-7.
12. 1-acid glycoprotein in rats. Inflammation 1992;16:197-203.
13. 1-protease inhibitor in human hepatoma cells. Eur J Cell Biol 1993;60:331-6.
14. 1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin Chim Acta 2000;294:93-103.
15. 1-acid glycoprotein in health and disease. Pharmacol Rev 1988;40:1-47.
16. 1-glycoprotein and its interactions with drugs. Drug Metab Rev 2001;33:161-235.
17. Logdberg L, Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 2000;1482:284-97.
18. 1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness. Immunology 1977;32:997-1005.
19. + currents in young and aged T-cell clones of C57BL/6 mice. Cell Signal 1999;11:391-8.
20. 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression. Immunology 1984;51:541-8.
21. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Langham CS, Parente L, et al. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol 1982;76:185-94.
22. Lee ES, Kim SW. Adsorbed glycoproteins in platelet adhesion onto polymer surfaces: significance of terminal galactose units. Trans Am Soc Artif Intern Organs 1979;25:124-32.
23. 1-Acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. Cancer 1997;80:1448-56.
24. 1-acid glycoprotein: importance of the carbohydrate moiety. Proc Natl Acad Sci USA 1980;77:6109-13.
25. 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants. Inflammation 1990;14:133-41.
26. Singh VK, Fudenberg HH. Lymphocyte stimulation in vitro by orosomucoid glycoprotein. Immunol Lett 1986;14:9-13.
27. 1-acid glycoprotein with polyacrylamide maintain the immunomodulating activity of native glycoprotein. Bioorg Khim 1994;20:994-1000.
28. Tamura K, Shibata Y, Matsuda Y, Ishida N. Isolation and characterization of an immunosuppressive acidic protein from acidic fluids of cancer patients. Cancer Res 1981;41:3244-52.
29. Samak R, Edelstein R, Israel L. Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer. Cancer Immunol Immunother 1982;13:38-43.
30. 1-acid glycoprotein and its possible role in the antitumor activity of some lichen polysaccharides. Chem Pharm Bull (Tokyo) 1986;34:2532-41.
31. 1-acid glycoprotein mRNA during rat development. High levels of expression in the decidua. J Biol Chem 1989;264:5784-90.
32. 1-acid glycoprotein mRNA shows regional specialization in rat decidua. Placenta 1993;14:417-28.
33. 1-acid glycoprotein. Clin Exp Immunol 1984;55:465-72.
34. 1-acid glycoprotein. Inflammation 1990;14:1-9.
35. 1-AGP) on the membrane of human lymphocytes: possible involvement in cellular activation. Immunol Lett 1987;15:167-70.
36. 1-acid glycoprotein on human polymorphonuclear neutrophils: influence of glycan microheterogeneity. Clin Chim Acta 1994;224:65-71.
37. Heyworth PG, Segal AW. Further evidence for the involvement of a phosphoprotein in the respiratory burst oxidase of human neutrophils. Biochem J 1986;239:723-31.
38. 1-acid glycoprotein. Arch Intern Med 1976;136:778-81.
39. 1-acid glycoprotein. Nature 1979;281:677-8.
40. 1-acid glycoprotein. Scand J Haematol 1980;24:365-72.
41. 1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction. Thromb Res 1979;15:857-68.
42. 1-acid glycoprotein. Biochim Biophys Acta 1976;427:302-14.
43. Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, et al. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993;92:1357-65.
44. 1-acid glycoprotein (orosomucoid). J Exp Med 1978;148:507-21.
45. 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity. J Biol Chem 2001;276:35305-11.
46. 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity. Biochem Biophys Res Commun 1987;147:710-5.
47. 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation 1990;14:315-23.
48. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J Exp Med 1993;178:1629-36.
49. 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis. Inflammation 1993;17:33-45.
50. 1-Acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1β interleukin-6 and tumor necrosis factor-α by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 1992;22:2687-95.
51. 1-acid glycoprotein on tissue factor expression and tumor necrosis factor secretion in human monocytes. Immunopharmacology 1996;34:139-45.
52. Soell M, Lett E, Holveck F, Scholler M, Wachsmann D, Klein JP. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. J Immunol 1995;154:851-60.
53. 1-Acid glycoprotein-induced tumor necrosis factor-α secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation. Immunopharmacology 1999;41:21-9.
54. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997:186:1793-8.
55. 1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages. Biochem J 2001;356:121-8.
56. Scuderi P, Dorr RT, Liddil JD, Finley PR, Meltzer P, Raitano AB, et al. Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. Eur J Immunol 1989;19:939-42.
57. 1-acid glycoprotein in cells in culture. Proc Soc Exp Biol Med 1980;163:223-7.
58. 1-acid glycoprotein. J Neurosci Res 1988;20:64-72.
59. 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 1994;180:1571-5.
60. 1-acid glycoprotein in different rodent models of shock. Fundam Clin Pharmacol 1998;12:173-81.
61. Rothe J, Mackay F, Bluethmann H, Zinkernagel R, Lesslauer W. Phenotypic analysis of TNFRI-deficient mice and characterization of TNFRI-deficient fibroblasts in vitro. Circ Shock 1994;44:51-6.
62. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94:8093-8.
63. 1-acid glycoprotein (orosomucoid), an acute-phase (inflammatory) reactant. Proc Natl Acad Sci USA 1983;80:5421-4.
64. 1 acid glycoprotein on the passage of erythrocytes through the membrane-filter. Life Sci 1980;27:157-61.
65. Athamna A, Kramer MR, Kahane I. Adherence of Mycoplasma pneumoniae to human alveolar macrophages. FEMS Immunol Med Microbiol 1996;15:135-41.
66. 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. J Biol Chem 2000;275:14903-9.
67. 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin. Arch Int Pharmacodyn Ther 1996;331:313-21.
68. Sörensson J, Ohlson M, Bjornson A, Haraldsson B. Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine. Am J Physiol Heart Circ Physiol 2000;278:H1725-1731.
69. Schnitzer JE, Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability. Am J Physiol 1992;263:H48-55.
70. Sörensson J, Matejka GL, Ohlson M, Haraldsson B. Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol 1999;276:H530-534.
71. DeFouw LM, DeFouw DO. Modulation of angiogenic endothelial permselectivity by the cAMP pathway. Microvasc Res 1999;57:19-29.
72. van Hinsberg VWM, van Nieuw Amerongen GP, Draijer R. Vascular endothelium. Physiology, pathology and therapeutic opportunities. In: Born GVR, Schwarz, CJ, editors. Regulation of the permeability of human endothelial cell monolayers. Stuttgart: Schattauer, 1997. p. 61-76.
73. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol 1998;274:H1885-94.
74. 1-acid glycoprotein (AAG). Biochem Pharmacol 1986;35:621-4.
75. Libert C, Van Molle W, Brouckaert P, Fiers W. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. J Inflamm 1995;46:139-43.
76. Wielockx B, Lannoy K, Shapiro SD, Itoh T, Itohara S, Vandekerckhove J, et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med 2001;7:1202-8.
77. 1-Acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis. Inflammation 1997;21:69-82.
78. 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 1997;159:3555-64.
79. Van Molle W, Denecker G, Rodriguez I, Brouckaert P, Vandenabeele P, Libert C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 1999;163:5235-41.
80. 1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice. Transgenic Res 1998;7:429-35.
81. 1-acid glycoprotein in transgenic mice. Glycobiology 1991;1:265-9.
82. 1-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 2000;102:1420-6.
83. 1-antichymotrypsin and haptoglobin. Glycoconjugate J 1998;15:177-82.
84. Haraldsson BS, Johnsson EK, Rippe B. Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid. Kidney Int 1992;41:310-6.
85. Johnsson E, Haraldsson B. Addition of purified orosomucoid preserves the glomerular permeability for albumin in isolated perfused rat kidneys. Acta Physiol Scand 1993;147:1-8.
86. 1-acid glycoprotein. J Biol Chem 1996;271:14492-5.
87. 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat. Am J Physiol 1997;273: 1031-5.
88. Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 1993;218:444-53.
89. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FD. Soluble complement receptor type I ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992;149:1723-8.
90. Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 1990;87:3982-6.
91. 1-acid glycoprotein (orosomucoid) on triglyceride metabolism in the nephrotic syndrome. Biochem Biophys Res Commun 1977;79:1272-8.
92. 1-acid glycoprotein on acute pancreatitis and acute lung injury in rats. Arzneimittelforschung 2000;50:987-94.
93. 1-acid-glyco-protein in urate crystal inflammation. Agents Actions 1984;15:539-40.
94. 1-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. Gut 2002;51:398-404.
95. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
96. 1-Acid glycoprotein: genetics, biochemistry, physiological functions and pharmacology. New York: AR Liss. 1989. p. 47-65.